Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06773013 · ClinicalTrials.gov registry record · NA
Safety and Effectiveness of Sonu for Pediatric Nasal Congestion
A NA study of Nasal Congestion and Inflammations, sponsored by Third Wave Therapeutics.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
- 1
- Study location
NCT06773013: Completed NA study of Nasal Congestion and Inflammations, sponsored by Third Wave Therapeutics.
NCT06773013 is a NA study of Nasal Congestion and Inflammations that has completed, run by Third Wave Therapeutics. The registered enrollment target is 31 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06773013, a NA study of Nasal Congestion and Inflammations, has completed, sponsored by Third Wave Therapeutics.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
- 1
- Study location
Study Summary
To demonstrate the safety and effectiveness of Sonu for the treatment of pediatric patients with moderate to severe nasal congestion.
Primary Outcome
Safety
Conditions Studied
Interventions
- DEVICE Acoustic Resonance (Sound) Therapy
Study Locations (1)
California
- Crescendo MD - Portola Valley
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2025-01-09 |
| Est. Completion | 2025-03-30 |
| Phase | NA |
What the finished NCT06773013 record still lists
NCT06773013 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 31 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Nasal Congestion and Inflammations appearing as the primary indexed condition, and to 1 intervention - of which Acoustic Resonance (Sound) Therapy is the first listed.
NCT06773013 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06773013 about?
NCT06773013 is a clinical study titled "Safety and Effectiveness of Sonu for Pediatric Nasal Congestion". To demonstrate the safety and effectiveness of Sonu for the treatment of pediatric patients with moderate to severe nasal congestion.
What is the current status of trial NCT06773013?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2025-01-09. Estimated completion is 2025-03-30.
What conditions does trial NCT06773013 study?
This clinical trial studies the following conditions: Nasal Congestion and Inflammations.
What interventions are being tested in trial NCT06773013?
The interventions under investigation include: Acoustic Resonance (Sound) Therapy (DEVICE).
Who is sponsoring clinical trial NCT06773013?
This trial is sponsored by Third Wave Therapeutics, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06773013 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nasal Congestion and Inflammations
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06773013's enrollment target sits among peer trials
31 1592nd of 2000 higher than 408 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02932618 · 31 participants · Phase 3
A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)
- NCT03482297 · 31 participants · Phase 1
Automated Abdominal Binder for Orthostatic Hypotension
- NCT04016389 · 31 participants · NA
FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
- NCT04211675 · 31 participants · Phase 1
NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI